# Armor Angels

> Armor Angels is a VC fund in Saint-brieuc backing Biotechnology and Medical Device. See 1 investment, round sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Saint-brieuc, France
- Total investments: 1
- Last investment: Mar 2017
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.armorangels.org

Armor Angels is a company that offers project financing services.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 1 | 100% |
| Medical Device | 1 | 100% |
| Product Research | 1 | 100% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Hemarina | Hemarina SA. is a privately held biotechnology company focused on the research, and development of oxygen-carriers for medical applications.Dr. Franck Zal, an expert in the field of invertebrate hemoglobin and oxygen transport, founded Hemarina after having spent more than fourteen years in academic research centers (CNRS, University ofCalifornia at Santa Barbara USA and University of Antwerpen, Belgium) studying the relationships between the structure and function of invertebrate respiratory pigment (annelidâ€™s extracellular hemoglobin and crustacean hemocyanin). The discoveries arising from his research on extracellular hemoglobin coming from marine invertebrates and their effective oxygen transport system have been patented and published in numerous scientific journals and form the basis of Hemarinaâ€™s technologies.Hemarinaâ€™s approach to the development of oxygen transport agents is based on the observation of marine worms colonizing extreme environments and the study of their respiratory adaptations.Hemarinaâ€™s lead product, HbAm, is designed to deliver oxygen effectively and efficiently to tissues at risk of oxygen deprivation. Hemarina has already a passed panel of strong proof of concepts obtained during preclinical trials. |  | Series C | Mar 15, 2017 |  |

1 of 1 investments shown.

## Co-investors
- [Crédit Mutuel Innovation](https://shizune.co/investors/profile/cm-cic-capital-innovation) — VC Fund, 1 deal together
- [Finistère Angels](https://shizune.co/investors/profile/finist-re-angels) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Armor Angels invest in?

Armor Angels invests primarily in Biotechnology, Medical Device and Product Research startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Armor Angels last invest?

The most recent investment recorded for Armor Angels closed in Mar 2017. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co
